FDA Drug recall D-206-2013
METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc
- FDA Drug
- Class II
- terminated
- Published 2013-03-27
On 2013-03-27 the FDA classified a Class II recall of METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc by Hospira, citing lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-206-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-02-15 |
| Published | 2013-03-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24)
Reason
Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.
Identifiers
| code_info | Lot code 12-074-JT Exp 12/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-206-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.